HERITAGE

  • 2013

    Omega Pharma acquires Arterin

  • 2013

    Omega Pharma buys Etixx

  • 2012

    Omega Pharma acquires OTC-brands of GSK Europe

  • 2012

    Delisting of Omega Pharma from NYSE/Euronext

  • 2010

    Acquisition of Laboratoire de la Mer, a world leader in natural Cough & Cold products

  • 2009

    Formation of the 50/50 joint venture with Modi-Mundipharma Group in India

  • 2009

    Sale of 24% stake in Arseus

  • 2008

    Various smaller acquisitions, including Aurora (Australia, New Zealand, Singapore), Interdelta (Switzerland), Altermed (Czech Republic and Slovakia), O+A Pharma (Hungary), Hipocrate (Romania), Fishem (Turkey), and Cinetic Laboratories (Argentina)

  • 2007

    Arseus carve-out via separate IPO

  • 2007

    Inclusion of Silence in the brand portfolio through the acquisition of Persee Médica

  • 2006

    Expansion into CEE and CIS through the acquisition of Bittner Pharma

  • 2004

    Acquisition of Wartner Europe

  • 2004

    Acquisition of 60 OTC brands from Pfizer which both expanded existing activities and provided access to new European countries such as Italy, Ireland, Scandinavia and Switzerland

  • 2004

    Expansion into Italy and Scandinavia via acquisitions

  • 2003

    Expansion into Greece

  • 2002

    Introduction in the Bel 20 index and expansion into Portugal

  • 2000

    Expansion into France through the acquisition of Pharmygiène

  • 2000

    Acquisition of Chefaro (AkzoNobel OTC) with operations in UK, Spain, Germany and The Netherlands

  • 2000

    Start of the internationalization process

  • 1998

    Start of the acquisition process on the Belgian home market

  • 1998

    IPO on Euronext Brussels

  • 1994

    Management buy-out by Marc Coucke

  • 1987

    Omega Pharma is created by two pharmacists, including Marc Coucke, the current CEO. With the slogan 'By pharmacists, for pharmacists' the founders of the Company began to build a Consumer Health organization in which the relationship with pharmacists plays a central role